Atlas Trials

Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 2: 7T MRI

Clinical trial NCT05233306 · COMPLETED

Trial details

NCT number
NCT05233306
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Status
COMPLETED
Study type
OBSERVATIONAL
Gilles de la Tourette SyndromeTourette Syndrome
Start date
2022-01-27
Primary completion
2023-04-06
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.